Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep Disturbances in Parkinson's Disease
NCT03258294Phase 4Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of melatonin in Parkinson's disease (PD). Status: unknown.
02
Drugs
melatonin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03258294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03258294.